Loncar Cancer Immunotherapy ETF (CNCR): Price and Financial Metrics ETF
CNCR Price/Volume Stats - 7 Best ETFs for the NEXT Bull Market
Current price | $16.62 | 52-week high | $17.96 |
Prev. close | $16.45 | 52-week low | $9.22 |
Day low | $16.48 | Volume | 12,300 |
Day high | $16.78 | Avg. volume | 34,341 |
50-day MA | $15.75 | Dividend yield | N/A |
200-day MA | $12.85 |
CNCR Stock Price Chart Interactive Chart >
Loncar Cancer Immunotherapy ETF (CNCR) ETF Bio
The investment objective of the Loncar Cancer Immunotherapy ETF seeks to replicate the Loncar Cancer Immunotherapy Index. The index was developed by a top biologist and includes large pharmaceutical and growth-oriented biotechnology firms that are focused on improving cancer treatments.
CNCR ETF Info
Issuer | Range ETFs |
Expense Ratio | 0.79% |
Underlying Index | Range Cancer Therapeutics Index |
Asset Class | Equity |
Sector | Health & Biotech ETFs |
Assets Under Management (AUM) | 17.12M |
Net Asset Value (NAV) | $16.62 |
Options? | Yes |
Total Holdings | N/A |
CNCR Top Holdings
Symbol | Company | % of Total |
CNCR Price Returns
1-mo | -3.93% |
3-mo | 23.39% |
6-mo | 51.71% |
1-year | 39.43% |
3-year | -38.43% |
5-year | -14.13% |
YTD | 23.39% |
2023 | -1.89% |
2022 | -42.31% |
2021 | -19.24% |
2020 | 36.53% |
2019 | 24.22% |